Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DFTX
Stock Latest News
Company Announcements
Definium Therapeutics Nears Pivotal Earnings Call Tests
5d ago
DFTX
Premium
Company Announcements
Definium Highlights Late-Stage Psychedelic-Inspired Psychiatric Pipeline
6d ago
8K
DFTX
Premium
The Fly
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
11d ago
ATAI
CMND
Premium
Ratings
Definium Therapeutics: Buy Rating Reiterated with Unchanged $70 Price Target on Robust Late-Stage DT120 Pipeline and De-Risked Phase 3 Programs
12d ago
DFTX
Premium
Ratings
Analyst Reiterates Buy on Definium Therapeutics as Late-Stage MDD and GAD Trials Advance; $38 Price Target Maintained
12d ago
DFTX
Premium
Company Announcements
Definium begins second Phase 3 trial for DT120
13d ago
8K
DFTX
Premium
The Fly
Definium Therapeutics says first patient dosed in Ascend study
13d ago
DFTX
Premium
Company Announcements
Mind Medicine Inc. Nears Pivotal DT120 Data
17d ago
DFTX
Premium
The Fly
Definium Therapeutics price target lowered to $48 from $49 at Piper Sandler
17d ago
DFTX
Premium
The Fly
Definium Therapeutics reports Q1 EPS (71c), consensus (49c)
18d ago
DFTX
Premium
Market News
Beyond Cannabis: 3 Stock Picks Tied to the Psychedelics Trade
26d ago
DFTX
MSOS
Premium
Ratings
Definium Therapeutics (DFTX): Late-Stage DT120 Psychedelic Pipeline and Multiple Near-Term Catalysts Support Buy Rating and $61 Target
1M ago
DFTX
Premium
Market News
3 Different Ways to Play the Rally in Psychedelic Stocks
1M ago
DFTX
NBIX
Premium
The Fly
Psychedelic: Exclusive talk with biopharma company Definium
1M ago
DFTX
Premium
The Fly
Definium Therapeutics price target raised to $40 from $25 at Oppenheimer
1M ago
DFTX
Premium
Ratings
Definium Therapeutics: Strengthened Investment Case and Multi-Indication Upside Ahead of Key Phase 3 Readouts
1M ago
DFTX
Premium
Company Announcements
Definium Highlights DT120 Phase 3 Progress in Depression, Anxiety
1M ago
8K
DFTX
Premium
The Fly
Definium Therapeutics highlights advancement of DT120 ODT
1M ago
DFTX
Premium
Ratings
Definium Therapeutics: Policy Tailwinds and Late-Stage Clinical Momentum Support Attractive Risk‑Reward and Higher $38 Price Target
1M ago
DFTX
Premium
Market News
Morning News Wrap-Up, 4/20/26: Today’s Biggest Stock Market Stories!
1M ago
AMD
DIA
Premium
The Fly
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
1M ago
BX
DX
Premium
Market News
How an Executive Order Boosted Definium Therapeutics Stock (DFTX) Today
1M ago
DFTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
